W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL
|
Back to Search Results |
|
Catalog Number BXAL083902E |
Device Problem
Device Dislodged or Dislocated (2923)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 08/30/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
No patient specific details have been provided.Therefore, the patient initials reflect the w.L.Gore internal case number.C1: cbas® heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Event Description
|
The following information was reported to gore: on (b)(6) 2023, a gore® viabahn® vbx balloon expandable endoprosthesis (vbx device) was intended for use in the innominate artery for a highly calcified lesion.It was reported, access was gained on the patient through the right arm using a biotronik fortress 8 fr x 45 cm introducer sheath, and the lesion was pre-dilated.The vbx device was advanced over an unknown brand and size rosen guidewire.It was noted the natural diameter of the lesion was approximately 10-11 mm, however, 10 mm and 11 mm vbx devices were not available.Therefore, the physician reportedly opted for a 8l mm x 39 mm vbx device.The vbx device catheter was able to advance across the target lesion, however, the vbx stent graft advanced too far.The physician then attempted to reposition the vbx stent graft and it separated from the balloon and became dislodged in front of the aortic arch with no visual damage noted.The vbx device catheter, guidewire, and introducer sheath were removed without difficulty.Ultimately, the vbx stent graft was retrieved via groin access with a snare.Another vbx device was successfully implanted in the initial treatment area without difficulty.There was no adverse event or consequences to the patient.
|
|
Search Alerts/Recalls
|
|
|